Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 20;12(1):1.
doi: 10.3390/pharmacy12010001.

Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey

Daisuke Ueki  1 , Shinya Suzuki  2 , Takahiro Ohta  3 , Akira Shinohara  2 , Yasukata Ohashi  4 , Daisuke Konuma  5 , Yasuaki Ryushima  6 , Ryoko Udagawa  7 , Hironori Motoshige  8 , Masahiro Ieoka  9 , Akihiro Taji  10 , Yuuki Kogure  11 , Mikako Hiraike  12 , Miyuki Uoi  13 , Kazuhiko Ino  1 , Toshikatsu Kawasaki  2 , Masakazu Yamaguchi  14
Affiliations

Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey

Daisuke Ueki et al. Pharmacy (Basel). .

Abstract

Although prescription review is an important role for pharmacists in anticancer drug therapy, there are no guidelines in Japan that specify what pharmacists should check for in chemotherapy regimens. This prospective multicenter survey aimed to investigate the implementation of chemotherapy regimen checks by pharmacists in general hospitals by focusing on 19 recommended confirmation items designed to enhance chemotherapy safety. This study involved 14 hospitals within the National Hospital Organization in different regions of Japan. The top five cancers in Japan (gastric, colorectal, lung, breast, and gynecological) were targeted and specific chemotherapy regimens were analyzed. This study assessed the amount of time required for regimen checks, the number of confirmation items completed, the number and the content of inquiries raised regarding prescriptions, and the pharmacists' opinions using a questionnaire that had a maximum score of 10 points. Pharmacists checked 345 and 375 chemotherapies of patients in the control group (CG) and recommended items group (RIG), respectively. The mean time periods required for completing a chemotherapy regimen check were 4 min and 14 s (SD ±1 min and 50 s) and 6 min and 18 s (SD, ±1 min and 7 s) in the CG and RIG, respectively. The mean of the recommended items for the CG = 12.4 and for the RIG = 18.6. The items that the pharmacists did not confirm included urine protein (sixty-nine cases, 18.4%), allergy history (four cases, 1%), previous history (two cases, 0.5%), and a previous history of hepatitis B virus (sixty-nine cases, 18.4%). The number of inquiries for a doctor's prescription order was higher in the RIG than in the CG (41 vs. 27 cases). This multicenter survey demonstrated the potential effectiveness of implementing 19 recommended confirmation items in the regimen checks by pharmacists in general hospitals other than cancer treatment collaborative base hospitals.

Keywords: cancer chemotherapy; chemotherapy regimen checks; hospital pharmacist; pharmacist intervention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. Mitchell G., Porter S., Manias E. Enabling sustained communication with patients for safe and effective management of oral chemotherapy: A longitudinal ethnography. J. Adv. Nurs. 2021;77:899–909. doi: 10.1111/jan.14634. - DOI - PubMed
    1. von Grünigen S., Geissbühler A., Bonnabry P. The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices. J. Oncol. Pharm. Pract. 2022;28:410–420. doi: 10.1177/1078155221995539. - DOI - PMC - PubMed
    1. Mulac A., Taxis K., Hagesaether E., Gerd Granas A. Severe and fatal medication errors in hospitals: Findings from the Norwegian incident reporting system. Eur. J. Hosp. Pharm. 2021;28:e56–e61. doi: 10.1136/ejhpharm-2020-002298. - DOI - PMC - PubMed
    1. Weiss B.D., Scott M., Demmel K., Kotagal U.R., Perentesis J.P., Walsh K.E. Significant and sustained reduction in chemotherapy errors through improvement science. J. Oncol. Pract. 2017;13:e329–e336. doi: 10.1200/JOP.2017.020842. - DOI - PubMed
    1. Raymond G., Kerry P. Chemotherapy medication errors in a pediatric cancer treatment center: Prospective characterization of error types and frequency and development of a quality improvement initiative to lower the error rate. Pediatr. Blood Cancer. 2012;60:1320–1324. - PubMed

LinkOut - more resources